Indications and uses
clears acne blemishes and allows skin to heal helps prevent new acne blemishes from forming
CeraVe Developed with Dermatologists Acne Control Acne Treatment
- Manufacturer
- L'Oreal USA Products Inc | L'OREAL USA PRODUCTS, INC.
- Effective date
- 2023-12-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 00:06:12
Label at a glance#
ProductCeraVe Developed with Dermatologists Acne Control Acne Treatment
Active ingredientSalicylic Acid
Label structure10 sections
Dosage and administration
• clean the skin thoroughly before applying this product • cover the entire affected area with a thin layer one to three times daily • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
Storage and handling
• store at 20 – 25ºC (68 – 77ºF) • protect from excessive moisture
Label contents#
Full prescribing information#
Active ingredient
Salicylic acid 2%
Purpose
Acne treatment
Uses
- clears acne blemishes and allows skin to heal
- helps prevent new acne blemishes from forming
Warnings
For external use only
When using this product
skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
• clean the skin thoroughly before applying this product
• cover the entire affected area with a thin layer one to three times daily
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day
Other information
• store at 20 – 25ºC (68 – 77ºF)
• protect from excessive moisture
Inactive ingredients
water, glycerin, sodium hydroxide, glycolic acid, lactic acid, niacinamide, ceramide NP, ceramide AP, ceramide EOP, carbomer, cetearyl alcohol, behentrimonium methosulfate, triethyl citrate, sodium hyaluronate, sodium lauroyl lactylate, cholesterol, chlorphenesin, disodium EDTA, hydroxypropyl guar, caprylyl glycol, xanthan gum, phytosphingosine, benzoic acid
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49967-172-01 | CeraVe Developed with Dermatologists Acne Control Acne Treatment | 1 in 1 CARTON | GEL | 1 | 2 | |
| 49967-172-01 | CeraVe Developed with Dermatologists Acne Control Acne Treatment | 40 mL in 1 TUBE | GEL | 40 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49967-172 | CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL ACNE TREATMENT (SALICYLIC ACID) GEL [L'OREAL USA PRODUCTS INC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240101_2532352e-eabc-4565-9437-b8801db6937a.zip |
Products#
Every source-derived product name is available through these pages.
- CeraVe Developed with Dermatologists Acne Control Acne Treatment
- Salicylic Acid
- WATER
- GLYCERIN
- SODIUM HYDROXIDE
- GLYCOLIC ACID
- LACTIC ACID
- NIACINAMIDE
- CERAMIDE NP
- CERAMIDE AP
- CERAMIDE 1
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE
- CETOSTEARYL ALCOHOL
- BEHENTRIMONIUM METHOSULFATE
- TRIETHYL CITRATE
- HYALURONATE SODIUM
- SODIUM LAUROYL LACTYLATE
- CHOLESTEROL
- CHLORPHENESIN
- EDETATE DISODIUM
- GUARAPROLOSE (1300 MPA.S AT 1%)
- CAPRYLYL GLYCOL
- XANTHAN GUM
- PHYTOSPHINGOSINE
- BENZOIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49967-172 | 49967-172-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CeraVe Developed with Dermatologists Acne Control Acne Treatment | SALICYLIC ACID | L'Oreal USA Products Inc | 2532352e-eabc-4565-9437-b8801db6937a | 2023-12-31 | Warnings | 49967-172-01 49967-172 49967017201 dc3ff666-19b7-4146-8eed-e28b7689274d 2532352e-eabc-4565-9437-b8801db6937a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.